Test your COVID-19 knowledge with this quick quiz
How up-to-date is your COVID-19 clinical knowledge? This four-part quiz series will test your knowledge and support learning. Look out for these fun fortnightly quizzes…
Promoted
RSV Research: Which Studies Stand Out?
Discover which RSV research publications top the list for global experts in the field. In this exclusive video, key opinion leaders share the studies that…
Demodex Mites: The Hidden Culprits Behind Rosacea
Rosacea, a chronic inflammatory skin condition, affects millions globally, primarily manifesting on the central face; cheeks, nose, chin, and forehead causing significant physical and emotional…
Case study: Managing drug interactions with COVID-19 antivirals
Like many respiratory illnesses, the burden of COVID-19 is greatest in older individuals. They are starkly over-represented in hospitalisation statistics — more than half of…
Manage IBS with Nerva digital hypnotherapy
Nerva is a digital gut-directed hypnotherapy (GDH) program that helps your patients address the root cause of their IBS, empowering them to take control of…
Q&A: What is insulin over-basalisation and how to avoid it
In this Q&A, Associate Professor Gary Kilov talks to AusDoc about the widespread problem of insulin over-basalisation in type 2 diabetes and what clinicians can…
Improve your practice and gain CPD points with MedicineInsight
Participating in MedicineInsight enhances your practice and supports your professional development by earning RACGP CPD points. Your data contributes to building the evidence for Australian…
Making Medical Cannabis Prescribing Safe, Simple, and Rewarding for Your Practice
Cannabis medicine offers exciting opportunities for healthcare providers with new tools to enhance patient outcomes. However, most healthcare providers feel they need more support in…
A quarter of at-risk CVD patients have high Lp(a): why does this matter?
The rates of lipoprotein (a) (Lp[a]) testing in Australia are astonishingly low, leaving patients with atherosclerotic cardiovascular disease (ASCVD) at increased risk of CV events…
Australian study uncovers critical gaps in cholesterol testing and treatment
High-risk patients with atherosclerotic cardiovascular disease are being let down by suboptimal lipid testing and treatment, a new Australian study has revealed.1,2 “The evidence base…
